Literature DB >> 23207867

Oral findings in patients with mucolipidosis type III.

Weber Céo Cavalcante1, Luciano Cincurá Silva Santos, Josiane Nascimento Dos Santos, Sara Juliana de Abreu de Vasconcellos, Roberto Almeida de Azevedo, Jean Nunes Dos Santos.   

Abstract

Mucolipidosis type III is a rare, autosomal recessive disorder, which is part of a group of storage diseases as a result of inborn error of lysosomal enzyme metabolism. It is characterized by the gradual onset of signs and symptoms affecting the physical and mental development as well as visual changes, heart, skeletal and joint. Although oral findings associated with mucolipidosis type II have been extensively reported, there is a shortage of information on mucolipidosis type III. This paper presents radiological and histological findings of multiple radiolucent lesions associated with impacted teeth in the jaw of a 16 year-old youngster with mucolipidosis type III.

Entities:  

Mesh:

Year:  2012        PMID: 23207867     DOI: 10.1590/s0103-64402012000400026

Source DB:  PubMed          Journal:  Braz Dent J        ISSN: 0103-6440


  3 in total

1.  Mucolipidosis Type III: A Rare Disease in Differential Diagnosis of Joint Stiffness in Pediatric Rheumatology.

Authors:  Çiğdem Seher Kasapkara; Meltem Akçaboy; Fehime Kara Eroğlu; Betül Emine Derinkuyu
Journal:  Arch Rheumatol       Date:  2017-05-25       Impact factor: 1.472

2.  Oral Health Status of Patients with Lysosomal Storage Diseases in Poland.

Authors:  Damian Drążewski; Małgorzata Grzymisławska; Katarzyna Korybalska; Natasza Czepulis; Marian Grzymisławski; Janusz Witowski; Anna Surdacka
Journal:  Int J Environ Res Public Health       Date:  2017-03-09       Impact factor: 3.390

3.  Mucolipidosis type III, a series of adult patients.

Authors:  Esmee Oussoren; David van Eerd; Elaine Murphy; Robin Lachmann; Jan C van der Meijden; Lies H Hoefsloot; Rob Verdijk; George J G Ruijter; Mario Maas; Carla E M Hollak; Janneke G Langendonk; Ans T van der Ploeg; Mirjam Langeveld
Journal:  J Inherit Metab Dis       Date:  2018-04-27       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.